CARBENOXOLONE
Carbenoxolone inhibits 11HSD and has antiulcer properties. Side effects include sodium retention, edema, and hypertension. Only GMP materials will be supplied, logistics all according to GDP.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of action
Carbenoxolone is a semi-synthetic derivative of glycyrrhetinic acid that modulates cellcell communication by inhibiting gap-junction channels formed by connexins, particularly connexin 43. It also affects 11-hydroxysteroid dehydrogenase (11-HSD) activity, thereby influencing local glucocorticoid metabolism. Through gap-junction blockade it reduces intercellular ion and metabolite exchange, altering electrical coupling and metabolic synchronisation between adjacent cells.
Benefits and advantages
Widely used as a pharmacological tool in neuroscience, cardiac electrophysiology, and epithelial/vascular biology to dissect gap-junctional intercellular communication. It supports research into seizure propagation, cardiac-conduction synchrony, astrocyteneuron signalling, and glucocorticoid-regulation pathways. Its dual action on connexins and 11-HSD makes it valuable in studies of tissue-specific cortisol activity.
Side effects and risks
Risks include mineralocorticoid-like effects such as sodium retention, oedema, hypertension and hypokalaemia due to interference with steroid metabolism. High concentrations may show off-target toxicity. Handle with care as a bioactive steroidal derivative.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C34H50O7 |
|---|---|
| Molecular Weight | 570.8 g/mol |
| CAS Number | 127-52-6 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | SOL IN 20 PARTS WATER, MORE SOL IN HOT WATER; IN 25 PARTS ETHANOL, YIELDING TURBID SOLN; VERY SPARINGLY SOL IN ETHER, CHLOROFORM /TRIHYDRATE/ |
| Purity | Purity information is available upon request (COA). |
| Synonym | carbenoxolone; Carbenoxolona; 5697-56-3; Carbenoxolonum; MM6384NG73 |
| IUPAC/Chemical Name | (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxypropanoyloxy)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid |
| InChl Key | OBZHEBDUNPOCJG-WBXJDKIVSA-N |
| InChl Code | InChI=1S/C34H50O7/c1-29(2)23-10-13-34(7)27(32(23,5)12-11-24(29)41-26(38)9-8-25(36)37)22(35)18-20-21-19-31(4,28(39)40)15-14-30(21,3)16-17-33(20,34)6/h18,21,23-24,27H,8-17,19H2,1-7H3,(H,36,37)(H,39,40)/t21-,23-,24-,27+,30+,31-,32-,33+,34+/m0/s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.


